Breo/Anoro: Just found info from GSK. Tier 2/3 unrestricted US patients access: Advair/Breo 50% commercial, 70% medicare; Anoro 75% commercial, 30% medicare. http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2014/Q2%202014%20launch%20metrics%20and%20pipeline%20progress.pdf